实用医学杂志 ›› 2023, Vol. 39 ›› Issue (14): 1798-1803.doi: 10.3969/j.issn.1006⁃5725.2023.14.012

• 临床研究 • 上一篇    下一篇

血清sFLT1、CTRP3水平与子宫内膜异位症的相关性 

吴玉良 吴春玲 吴丹    

  1. 江西省景德镇市妇幼保健院妇产科(江西景德镇 333000)
  • 出版日期:2023-07-25 发布日期:2023-07-25

The correlation of endometriosis with serum levels of FLT1 and CTRP3 

WU Yuliang,WU Chunling,WU Dan.    

  1. Department of Gynaecology and Obstetrics,Jingdezhen City Maternal and Child Health Care Hospital,Jingde⁃ zhen 333000,China 
  • Online:2023-07-25 Published:2023-07-25
  • Supported by:
    江西省卫生健康委员会科技计划项目(编号:20204361) 

摘要:

目的 探究血清可溶性血管内皮生长因子受体 1(soluble vascular endothelial growth factor receptor⁃1,sFLT1)、C1q/肿瘤坏死因子相关蛋白 3(C1q/tumor necrosis factor related protein 3,CTRP3)与子宫 内膜异位症(endometriosis,EMT)的相关性。方法 回顾性分析江西省景德镇市妇幼保健院收治的 80 例 EMT 患者(EMT 组),依据 r⁃AFS 分期分为Ⅰ-Ⅱ期 43 例,Ⅲ-Ⅳ期 37 例,按痛经程度分为轻度 46 例,中-重 度 34 例;对照组为同时间段健康体检女性 80 例;检测并分析两组血清 sFLT1、CTRP3 水平,多因素 logistic 回归分析Ⅲ-Ⅳ期 EMT 影响因素,受试者工作特征曲线(receiver operating characteristic curve,ROC)评价 血清 sFLT1、CTRP3 对Ⅲ-Ⅳ期 EMT 诊断价值。结果 EMT 组患者血清 sFLT1、CTRP3 水平低于对照组 (P < 0.05);中-重度痛经者血清 sFLT1、CTRP3 水平低于轻度者(P < 0.05);r⁃AFS 分期Ⅲ-Ⅳ期患者血清 sFLT1、CTRP3 水平低于Ⅰ-Ⅱ期者(P < 0.05);EMT 患者血清 sFLT1、CTRP3 分别与 r⁃AFS 分期、痛经程度 呈负相关(P < 0.05)。回归分析显示,sFLT1、CTRP3 是Ⅲ-Ⅳ期 EMT 影响因素(P < 0.05);血清 sFLT1、 CTRP3 及联合诊断Ⅲ-Ⅳ期 EMT 的 AUC 为 0.811、0.832、0.931,联合诊断效能优于 sFLT1、CTRP3 单独诊断。结论 EMT 患者血清 sFLT1、CTRP3 水平均降低,与痛经程度、r⁃AFS 分期相关,是Ⅲ-Ⅳ期 EMT 影响 因素,二者联合可辅助评估 r⁃AFS 分期。 

关键词: 子宫内膜异位症, 可溶性血管内皮生长因子受体 1, C1q/肿瘤坏死因子相关蛋白 3, r?AFS 分期, 痛经

Abstract:

Objective To explore the association of endometriosis(EMT)with serum soluble vascular endothelial growth factor receptor ⁃1(sFLT1)and C1q/tumor necrosis factor related protein 3(CTRP3). Methods A retrospective analysis was conducted on 80 EMT patients(EMT group)admitted to Jingdezhen Maternal and Child Health Hospital. According to r⁃AFS staging,43 patients were diagnosed as stage Ⅰ-Ⅱ and 37 as stage Ⅲ-Ⅳ. According to the degree of dysmenorrhea,46 patients were classified as mild and 34 as moderate to severe. The control group consisted of 80 women receiving physical examinations during the same period of time. Serum levels of sFLT1 and CTRP3 were detected and analyzed in both groups The influencing factors of EMT in stage Ⅲ to Ⅳ were analyzed by multivariate logistic regression. The receiver operating characteristic curve(ROC)was applied to evaluate the diagnostic value of serum sFLT1 and CTRP3 for stage Ⅲ-Ⅳ EMT. Results Serum levels of sFLT1 and CTRP3 in the EMT group were lower than those in the control group(P < 0.05),serum sFLT1 and CTRP3 levels in moderate to severe dysmenorrhea patients were lower than those in mild dysmenorrhea patients(P < 0.05), and serum sFLT1 and CTRP3 levels in r⁃AFS stage Ⅲ to Ⅳ were lower than those in stage Ⅰ to Ⅱ(P < 0.05). Correlation analysis showed that serum sFLT1 and CTRP3 in EMT patients were negatively correlated with r⁃AFS staging and degree of dysmenorrhea(P < 0.05),respectively. Regression analysis showed that sFLT1 and CTRP3 were the influencing factors for stage Ⅲ-Ⅳ EMT(P < 0.05). The AUC values of serum sFLT1 and CTRP3 in com⁃ bination with diagnosis of stage Ⅲ-Ⅳ EMT were 0.811,0.832,and 0.931,respectively;the combined diagnostic efficacy was better than that of sFLT1 and CTRP3 alone. Conclusions Serum levels of sFLT1 and CTRP3 decrease in EMT patients,which are related to the degree of dysmenorrhea and r⁃AFS staging and are influencing factors for stage Ⅲ-Ⅳ EMT. sFLT1 combined with CTRP3 is helpful in the assessment of r⁃AFS stage. 

Key words: endometriosis, soluble vascular endothelial growth factor receptor?1, C1q/tumor necrosis factor related protein 3, r?AFS staging, dysmenorrhea